$ASTY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Asterias Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Asterias Biotherapeutics, Inc.. Get notifications about new insider transactions in Asterias Biotherapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2019 | ASTY | Asterias Biotherap ... | BROADWOOD PARTNERS, L.P. | Sell | J | 0.00 | 5,292,156 | 0 | 0 | 5.3 M to 0 (-100.00 %) | |
| Mar 05 2019 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Payment of Exercise | F | 0.95 | 48,826 | 46,385 | 267,194 | 316 K to 267.2 K (-15.45 %) |
| Mar 05 2019 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Grant | A | 0.00 | 156,452 | 0 | 316,020 | 159.6 K to 316 K (+98.05 %) |
| Mar 05 2019 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Payment of Exercise | F | 0.95 | 76,588 | 72,759 | 273,622 | 350.2 K to 273.6 K (-21.87 %) |
| Mar 05 2019 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Grant | A | 0.00 | 252,606 | 0 | 350,210 | 97.6 K to 350.2 K (+258.81 %) |
| Mar 05 2019 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Payment of Exercise | F | 0.95 | 44,471 | 42,247 | 255,509 | 300 K to 255.5 K (-14.82 %) |
| Mar 05 2019 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Grant | A | 0.00 | 145,263 | 0 | 299,980 | 154.7 K to 300 K (+93.89 %) |
| Jan 04 2019 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Payment of Exercise | F | 0.68 | 20,440 | 13,899 | 154,717 | 175.2 K to 154.7 K (-11.67 %) |
| Jan 04 2019 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Payment of Exercise | F | 0.68 | 20,440 | 13,899 | 159,568 | 180 K to 159.6 K (-11.36 %) |
| Aug 29 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.59 | 3,141 | 5,000 | 97,604 | 94.5 K to 97.6 K (+3.33 %) |
| Jul 27 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.69 | 2,950 | 5,000 | 94,463 | 91.5 K to 94.5 K (+3.22 %) |
| Jun 27 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.63 | 3,067 | 4,999 | 91,513 | 88.4 K to 91.5 K (+3.47 %) |
| Jun 25 2018 | ASTY | Asterias Biotherap ... | Scher Howard Isador | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | ||
| Jun 25 2018 | ASTY | Asterias Biotherap ... | RICCIARDI NATALE S | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | ||
| Jun 25 2018 | ASTY | Asterias Biotherap ... | LeBuhn Richard T. | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | ||
| Jun 25 2018 | ASTY | Asterias Biotherap ... | Cartt Stephen LaHue | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | ||
| Jun 25 2018 | ASTY | Asterias Biotherap ... | BAILEY DON M | Option Exercise | A | 1.75 | 75,000 | 131,250 | 75,000 | ||
| Jun 25 2018 | ASTY | Asterias Biotherap ... | Arno Andrew | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | ||
| May 31 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.59 | 3,153 | 5,000 | 88,446 | 85.3 K to 88.4 K (+3.70 %) |
| Apr 27 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.33 | 3,752 | 4,990 | 85,293 | 81.5 K to 85.3 K (+4.60 %) |
| Mar 30 2018 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Payment of Exercise | F | 1.45 | 6,483 | 9,400 | 180,008 | 186.5 K to 180 K (-3.48 %) |
| Mar 30 2018 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Payment of Exercise | F | 1.45 | 6,483 | 9,400 | 175,157 | 181.6 K to 175.2 K (-3.57 %) |
| Mar 28 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 1.76 | 2,839 | 4,997 | 81,541 | 78.7 K to 81.5 K (+3.61 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Option Exercise | A | 1.95 | 200,000 | 390,000 | 200,000 | |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Payment of Exercise | F | 1.95 | 28,358 | 55,298 | 78,702 | 107.1 K to 78.7 K (-26.49 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Grant | A | 0.00 | 94,872 | 0 | 107,060 | 12.2 K to 107.1 K (+778.40 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Option Exercise | A | 1.95 | 150,000 | 292,500 | 150,000 | |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Payment of Exercise | F | 1.95 | 22,686 | 44,238 | 186,491 | 209.2 K to 186.5 K (-10.85 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Grant | A | 0.00 | 74,000 | 0 | 209,177 | 135.2 K to 209.2 K (+54.74 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Grant | A | 0.00 | 50,000 | 0 | 135,177 | 85.2 K to 135.2 K (+58.70 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Option Exercise | A | 1.95 | 150,000 | 292,500 | 150,000 | |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Payment of Exercise | F | 1.95 | 21,633 | 42,184 | 181,640 | 203.3 K to 181.6 K (-10.64 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Grant | A | 0.00 | 68,708 | 0 | 203,273 | 134.6 K to 203.3 K (+51.06 %) |
| Mar 19 2018 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Grant | A | 0.00 | 50,000 | 0 | 134,565 | 84.6 K to 134.6 K (+59.13 %) |
| Feb 28 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.22 | 2,255 | 5,000 | 12,188 | 9.9 K to 12.2 K (+22.70 %) |
| Jan 26 2018 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.34 | 2,134 | 5,000 | 9,933 | 7.8 K to 9.9 K (+27.36 %) |
| Dec 28 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.22 | 2,247 | 4,988 | 7,799 | 5.6 K to 7.8 K (+40.47 %) |
| Nov 29 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.41 | 2,076 | 5,003 | 5,552 | 3.5 K to 5.6 K (+59.72 %) |
| Oct 27 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 2.55 | 1,939 | 4,944 | 3,476 | 1.5 K to 3.5 K (+126.15 %) |
| Oct 18 2017 | ASTY | Asterias Biotherap ... | BROADWOOD PARTNERS, L.P. | Buy | P | 2.60 | 1,592,308 | 4,140,001 | 5,292,156 | 3.7 M to 5.3 M (+43.04 %) | |
| Sep 27 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Buy | P | 3.25 | 1,537 | 4,997 | 1,537 | 0 to 1.5 K |
| Jun 28 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | EVP & COO | Option Exercise | A | 3.70 | 50,000 | 185,000 | 50,000 | |
| Jun 28 2017 | ASTY | Asterias Biotherap ... | Cartt Stephen LaHue | Option Exercise | A | 3.70 | 20,000 | 74,000 | 20,000 | ||
| Jun 28 2017 | ASTY | Asterias Biotherap ... | Mulroy Michael H. | President and CEO | Option Exercise | A | 3.70 | 800,000 | 2,960,000 | 800,000 | |
| Jun 07 2017 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Payment of Exercise | F | 3.20 | 6,745 | 21,584 | 85,177 | 91.9 K to 85.2 K (-7.34 %) |
| Jun 07 2017 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | Chief Scientific Of ... | Payment of Exercise | F | 3.20 | 7,015 | 22,448 | 102,991 | 110 K to 103 K (-6.38 %) |
| Jun 07 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | EVP & COO | Payment of Exercise | F | 3.20 | 7,260 | 23,232 | 10,949 | 18.2 K to 10.9 K (-39.87 %) |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Arno Andrew | Option Exercise | A | 3.45 | 20,000 | 69,000 | 20,000 | ||
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Grant | A | 0.00 | 75,000 | 0 | 91,922 | 16.9 K to 91.9 K (+443.21 %) |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Grant | A | 0.00 | 16,922 | 0 | 16,922 | 0 to 16.9 K |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | RICCIARDI NATALE S | Option Exercise | A | 3.45 | 20,000 | 69,000 | 20,000 | ||
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Cartt Stephen LaHue | President and CEO | Option Exercise | A | 3.45 | 200,000 | 690,000 | 200,000 | |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Cartt Stephen LaHue | President and CEO | Grant | A | 0.00 | 32,783 | 0 | 292,783 | 260 K to 292.8 K (+12.61 %) |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Scher Howard Isador | Option Exercise | A | 3.45 | 20,000 | 69,000 | 20,000 | ||
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Grant | A | 0.00 | 75,000 | 0 | 84,565 | 9.6 K to 84.6 K (+784.11 %) |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | CFO and General Cou ... | Grant | A | 0.00 | 9,565 | 0 | 9,565 | 0 to 9.6 K |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Grant | A | 0.00 | 75,000 | 0 | 110,006 | 35 K to 110 K (+214.25 %) |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Grant | A | 0.00 | 17,670 | 0 | 35,006 | 17.3 K to 35 K (+101.93 %) |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | BAILEY DON M | Option Exercise | A | 3.45 | 75,000 | 258,750 | 75,000 | ||
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Option Exercise | A | 3.45 | 150,000 | 517,500 | 150,000 | |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Grant | A | 0.00 | 18,209 | 0 | 18,209 | 0 to 18.2 K |
| Apr 03 2017 | ASTY | Asterias Biotherap ... | LeBuhn Richard T. | Option Exercise | A | 3.45 | 20,000 | 69,000 | 20,000 | ||
| Jan 11 2017 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Payment of Exercise | F | 0.00 | 2,537 | 0 | 17,336 | 19.9 K to 17.3 K (-12.77 %) |
| Jan 11 2017 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Sell | S | 4.60 | 3,415 | 15,719 | 0 | 3.4 K to 0 (-100.00 %) |
| Jan 11 2017 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 2,056 | 0 | 3,415 | 5.5 K to 3.4 K (-37.58 %) |
| Jan 11 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Sell | S | 4.60 | 4,781 | 22,007 | 0 | 4.8 K to 0 (-100.00 %) |
| Jan 11 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Payment of Exercise | F | 0.00 | 2,878 | 0 | 4,781 | 7.7 K to 4.8 K (-37.58 %) |
| Jan 06 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Option Exercise | M | 2.34 | 2,500 | 5,850 | 192,500 | |
| Jan 06 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Sell | S | 5.00 | 2,500 | 12,500 | 0 | 2.5 K to 0 (-100.00 %) |
| Jan 06 2017 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Buy | M | 2.34 | 2,500 | 5,850 | 2,500 | 0 to 2.5 K |
| Jan 06 2017 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Option Exercise | M | 2.34 | 2,500 | 5,850 | 192,500 | |
| Jan 06 2017 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Sell | S | 5.00 | 2,500 | 12,500 | 0 | 2.5 K to 0 (-100.00 %) |
| Jan 06 2017 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Buy | M | 2.34 | 2,500 | 5,850 | 2,500 | 0 to 2.5 K |
| Nov 28 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Option Exercise | M | 2.34 | 2,500 | 5,850 | 195,000 | |
| Nov 28 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Sell | S | 5.41 | 2,500 | 13,525 | 0 | 2.5 K to 0 (-100.00 %) |
| Nov 28 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Buy | M | 2.34 | 2,500 | 5,850 | 2,500 | 0 to 2.5 K |
| Nov 21 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Option Exercise | M | 2.34 | 2,500 | 5,850 | 197,500 | |
| Nov 21 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Sell | S | 5.00 | 2,500 | 12,500 | 0 | 2.5 K to 0 (-100.00 %) |
| Nov 21 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Buy | M | 2.34 | 2,500 | 5,850 | 2,500 | 0 to 2.5 K |
| Nov 21 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Option Exercise | M | 2.34 | 2,500 | 5,850 | 197,500 | |
| Nov 21 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Sell | S | 5.00 | 2,500 | 12,500 | 0 | 2.5 K to 0 (-100.00 %) |
| Nov 21 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Buy | M | 2.34 | 2,500 | 5,850 | 2,500 | 0 to 2.5 K |
| Oct 11 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Sell | S | 4.11 | 4,781 | 19,635 | 0 | 4.8 K to 0 (-100.00 %) |
| Oct 11 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Payment of Exercise | F | 0.00 | 2,878 | 0 | 4,781 | 7.7 K to 4.8 K (-37.58 %) |
| Oct 11 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Sell | S | 4.12 | 3,415 | 14,084 | 0 | 3.4 K to 0 (-100.00 %) |
| Oct 11 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 2,055 | 0 | 3,415 | 5.5 K to 3.4 K (-37.57 %) |
| Oct 11 2016 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Payment of Exercise | F | 0.00 | 2,537 | 0 | 13,121 | 15.7 K to 13.1 K (-16.20 %) |
| Sep 12 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Sell | S | 3.54 | 9,608 | 33,989 | 0 | 9.6 K to 0 (-100.00 %) |
| Sep 12 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Sell | S | 3.50 | 9,728 | 34,048 | 9,608 | 19.3 K to 9.6 K (-50.31 %) |
| Sep 12 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Sell | S | 3.58 | 3,179 | 11,384 | 0 | 3.2 K to 0 (-100.00 %) |
| Sep 12 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Sell | S | 3.50 | 11,581 | 40,534 | 3,179 | 14.8 K to 3.2 K (-78.46 %) |
| Jul 19 2016 | ASTY | Asterias Biotherap ... | Chavez Ryan Daniel | Exec. VP of Fin & G ... | Option Exercise | A | 2.91 | 380,000 | 1,105,800 | 380,000 | |
| Jul 01 2016 | ASTY | Asterias Biotherap ... | LeBuhn Richard T. | Director | Buy | P | 2.38 | 5,000 | 11,900 | 25,000 | 20 K to 25 K (+25.00 %) |
| Jul 01 2016 | ASTY | Asterias Biotherap ... | Cartt Stephen LaHue | President and CEO | Buy | P | 2.40 | 10,000 | 23,977 | 260,000 | 250 K to 260 K (+4.00 %) |
| Jun 13 2016 | ASTY | Asterias Biotherap ... | Cartt Stephen LaHue | President and CEO | Buy | P | 2.93 | 50,000 | 146,530 | 250,000 | 200 K to 250 K (+25.00 %) |
| Jun 10 2016 | ASTY | Asterias Biotherap ... | KINGSLEY ALFRED D | Director | Buy | P | 2.93 | 4,000 | 11,720 | 9,000 | 5 K to 9 K (+80.00 %) |
| May 17 2016 | ASTY | Asterias Biotherap ... | BAILEY DON M | Director | Option Exercise | P | 4.37 | 44,117 | 192,791 | 44,117 | |
| May 17 2016 | ASTY | Asterias Biotherap ... | BAILEY DON M | Director | Buy | P | 3.39 | 88,235 | 299,117 | 88,235 | 0 to 88.2 K |
| May 17 2016 | ASTY | Asterias Biotherap ... | LeBuhn Richard T. | Director | Option Exercise | P | 4.37 | 7,500 | 32,775 | 7,500 | |
| May 17 2016 | ASTY | Asterias Biotherap ... | LeBuhn Richard T. | Director | Buy | P | 3.39 | 15,000 | 50,850 | 20,000 | 5 K to 20 K (+300.00 %) |
| May 17 2016 | ASTY | Asterias Biotherap ... | RICCIARDI NATALE S | Director | Option Exercise | P | 4.37 | 7,353 | 32,133 | 7,353 | |
| May 17 2016 | ASTY | Asterias Biotherap ... | RICCIARDI NATALE S | Director | Buy | P | 3.39 | 14,706 | 49,853 | 19,706 | 5 K to 19.7 K (+294.12 %) |
| May 13 2016 | ASTY | Asterias Biotherap ... | BROADWOOD PARTNERS LP | Option Exercise | P | 4.37 | 1,029,412 | 4,498,530 | 1,029,412 | ||
| May 13 2016 | ASTY | Asterias Biotherap ... | BROADWOOD PARTNERS LP | Buy | P | 0.00 | 2,058,823 | 0 | 3,699,848 | 1.6 M to 3.7 M (+125.46 %) | |
| Apr 29 2016 | ASTY | Asterias Biotherap ... | Scher Howard Isador | Director | Option Exercise | A | 4.21 | 20,000 | 84,200 | 20,000 | |
| Mar 29 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Grant | A | 0.00 | 30,635 | 0 | 30,635 | 0 to 30.6 K |
| Mar 29 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Grant | A | 0.00 | 21,882 | 0 | 21,882 | 0 to 21.9 K |
| Mar 29 2016 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Grant | A | 0.00 | 27,007 | 0 | 27,007 | 0 to 27 K |
| Mar 02 2016 | ASTY | Asterias Biotherap ... | BIOTIME INC | 10% Owner | Option Exercise | J | 5.00 | 3,150,000 | 15,750,000 | 0 | |
| Mar 02 2016 | ASTY | Asterias Biotherap ... | BIOTIME INC | 10% Owner | Sell | J | 0.00 | 75,771 | 0 | 21,747,569 | 21.8 M to 21.7 M (-0.35 %) |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | BAILEY DON M | Director | Option Exercise | A | 3.64 | 75,000 | 273,000 | 75,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | LeBuhn Richard T. | Director | Option Exercise | A | 3.64 | 20,000 | 72,800 | 20,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | RICCIARDI NATALE S | Director | Option Exercise | A | 3.64 | 20,000 | 72,800 | 20,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Option Exercise | A | 3.64 | 165,000 | 600,600 | 165,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Option Exercise | A | 3.64 | 165,000 | 600,600 | 165,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | Arno Andrew | Director | Option Exercise | A | 3.64 | 20,000 | 72,800 | 20,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | Peabody Robert | Director | Option Exercise | A | 3.64 | 20,000 | 72,800 | 20,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | KINGSLEY ALFRED D | Director | Option Exercise | A | 3.64 | 20,000 | 72,800 | 20,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | Cartt Stephen LaHue | President and CEO | Option Exercise | A | 3.64 | 1,000,000 | 3,640,000 | 1,000,000 | |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | Cartt Stephen LaHue | President and CEO | Grant | A | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
| Mar 01 2016 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Option Exercise | A | 3.64 | 120,000 | 436,800 | 120,000 | |
| Jan 19 2016 | ASTY | Asterias Biotherap ... | LICHTINGER PEDRO | President & CEO | Option Exercise | A | 3.90 | 200,000 | 780,000 | 200,000 | |
| Nov 12 2015 | ASTY | Asterias Biotherap ... | Erbez Georgia | Exec VP & CFO | Option Exercise | A | 5.16 | 380,000 | 1,960,800 | 380,000 | |
| Nov 06 2015 | ASTY | Asterias Biotherap ... | Spink Katharine E. | Chief Operating Off ... | Option Exercise | A | 5.45 | 100,000 | 545,000 | 100,000 | |
| Sep 16 2015 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Sell | S | 6.00 | 4,912 | 29,472 | 476 | 5.4 K to 476 (-91.17 %) |
| Sep 16 2015 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Sell | S | 6.00 | 2,880 | 17,280 | 0 | 2.9 K to 0 (-100.00 %) |
| Sep 16 2015 | ASTY | Asterias Biotherap ... | Spink Katharine E. | VP and Chief Operat ... | Sell | S | 6.00 | 3,760 | 22,560 | 0 | 3.8 K to 0 (-100.00 %) |
| Jul 13 2015 | ASTY | Asterias Biotherap ... | RICCIARDI NATALE S | Director | Option Exercise | A | 6.22 | 20,000 | 124,400 | 20,000 | |
| Jul 13 2015 | ASTY | Asterias Biotherap ... | Arno Andrew | Director | Option Exercise | A | 6.22 | 20,000 | 124,400 | 20,000 | |
| Jul 13 2015 | ASTY | Asterias Biotherap ... | LeBuhn Richard T. | Director | Option Exercise | A | 6.22 | 20,000 | 124,400 | 20,000 | |
| Jul 02 2015 | ASTY | Asterias Biotherap ... | Spink Katharine E. | VP and Chief Operat ... | Payment of Exercise | F | 4.60 | 3,291 | 15,139 | 3,760 | 7.1 K to 3.8 K (-46.67 %) |
| Jul 02 2015 | ASTY | Asterias Biotherap ... | Wirth Edward | Chief Medical Offic ... | Payment of Exercise | F | 4.60 | 1,668 | 7,673 | 2,880 | 4.5 K to 2.9 K (-36.68 %) |
| Jul 02 2015 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Payment of Exercise | F | 4.60 | 2,844 | 13,082 | 5,388 | 8.2 K to 5.4 K (-34.55 %) |
| Jun 26 2015 | ASTY | Asterias Biotherap ... | LeBuhn Richard T. | Director | Buy | P | 4.41 | 5,000 | 22,062 | 5,000 | 0 to 5 K |
| Jun 26 2015 | ASTY | Asterias Biotherap ... | KINGSLEY ALFRED D | Director | Buy | P | 4.32 | 5,000 | 21,577 | 5,000 | 0 to 5 K |
| Jun 26 2015 | ASTY | Asterias Biotherap ... | Arno Andrew | Director | Buy | P | 4.32 | 5,000 | 21,600 | 5,000 | 0 to 5 K |
| Jun 26 2015 | ASTY | Asterias Biotherap ... | RICCIARDI NATALE S | Director | Buy | P | 4.40 | 5,000 | 21,975 | 5,000 | 0 to 5 K |
| May 26 2015 | ASTY | Asterias Biotherap ... | BROADWOOD PARTNERS LP | Option Exercise | X | 2.34 | 1,000,000 | 2,340,000 | 0 | ||
| May 26 2015 | ASTY | Asterias Biotherap ... | BROADWOOD PARTNERS LP | Buy | X | 2.34 | 1,000,000 | 2,340,000 | 1,641,025 | 641 K to 1.6 M (+156.00 %) | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | WEST MICHAEL D | VP of Technology In ... | Option Exercise | A | 0.00 | 3,846 | 0 | 3,846 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | WEST MICHAEL D | VP of Technology In ... | Option Exercise | A | 3.90 | 20,000 | 78,000 | 20,000 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | LICHTINGER PEDRO | Chief Executive Off ... | Option Exercise | A | 0.00 | 23,932 | 0 | 23,932 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | LICHTINGER PEDRO | Chief Executive Off ... | Option Exercise | A | 3.90 | 200,000 | 780,000 | 200,000 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | Peabody Robert | Chief Financial Off ... | Option Exercise | A | 0.00 | 3,846 | 0 | 3,846 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | Peabody Robert | Chief Financial Off ... | Option Exercise | A | 3.90 | 50,000 | 195,000 | 50,000 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | SEGALL JUDITH | Corporate Secretary | Option Exercise | A | 3.90 | 20,000 | 78,000 | 20,000 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | Spink Katharine E. | VP and Chief Operat ... | Option Exercise | A | 0.00 | 28,205 | 0 | 28,205 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | Spink Katharine E. | VP and Chief Operat ... | Option Exercise | A | 3.90 | 100,000 | 390,000 | 100,000 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Option Exercise | A | 0.00 | 31,025 | 0 | 31,025 | |
| Feb 18 2015 | ASTY | Asterias Biotherap ... | LEBKOWSKI JANE | President of R&D | Option Exercise | A | 3.90 | 100,000 | 390,000 | 100,000 |